PG05: Embryo Development: New Technologies and Science
Time:8:15 am - 5:00 pm
Location:Room 7 - San Diego Convention Center
Carlos Simón, M.D., Ph.D. (Co-Chair), Fundación IVI
Renee A. Reijo Pera, Ph.D. (Co-Chair), The Institute for Stem Cell Biology and Regenerative Medicine
Marcos Meseguer, Ph.D., Instituto Valenciano de Infertilidad
William Schoolcraft, M.D., Colorado Center for Reproductive Medicine
PG Chair Choice
NEEDS ASSESSMENT AND COURSE DESCRIPTION
Human embryo viability and aneuploidy are currently assessed by morphological and genomic techniques, but are far from being completely understood. There is a need for practical knowledge that is clinically applicable and basic knowledge that will contribute to scientific progress in this field.
This live course, aimed at obstetrician/gynecologists, embryologists and geneticists, as well as laboratory scientists and technicians, will update participants on the clinical relevance of new technologies applied to assess human embryo viability and aneuploidy from imaging to genomics, proteomics and metabolomics, as well as the future of the “new” IVF lab.
At the conclusion of this course, participants should be able to:
- Describe the mechanisms implicated in human embryonic development, blastomere fate and embryonic genome activation.
- Summarize the clinical relevance of noninvasive imaging to assess embryo viability and improve clinical outcome.
- Explain the practical relevance of invasive comprehensive chromosome screening after trophectoderm biopsy and evaluate the translational relevance of noninvasive proteomic and metabolomic markers in embryo viability and aneuploidy.
- Describe the clinical value of the vitrification program through oocyte and embryo development.
- Discuss the future possibilities in the IVF lab.